Oncology Reports · 2015 · 59 citations · 24 references
MedicineOncologyPharmacologyApoptosisCancer PharmacologyMolecular OncologyApoptosis In CancerApoptosis PharmacologyAnticancer ActivityBcl-2 Protein ExpressionCancer Metastasis MechanismsHepatic ApoptosisHepatic Cell Culture ModelsNf-κb SignalingP53-dependent Apoptotic SignalingP53-mediated Apoptosis
Xanthohumol may prevent and cure diabetes and atherosis, have oxidation resistance and antiviral function as well as anticancer effect preventing cancer cell metastasis. We investigate whether the anticancer effect of xanthohumol induces growth inhibition and apoptosis of human liver cancer through NF-κB/p53-apoptosis signaling pathway. Human liver cancer HepG2 cell were treated with 10, 20, 30 and 40 µM xanthohumol for 48 h. The present study showed that the anticancer effect of xanthohumol was effective in inhibiting proliferation and inducing apoptosis of human liver cancer HepG2 cells. Furthermore, the caspase-3 activity of human liver cancer HepG2 cells was increased by xanthohumol. In addition, 48-h treatment with xanthohumol suppressed NF-κB expression and promoted p53, cleaved PARP, AIF and cytochrome c expression and downregulated XIAP and Bcl-2/Bax expression in human liver cancer HepG2 cells. Therefore, the anticancer effect of xanthohumol induces growth inhibition and apoptosis of human liver cancer through the NF-κB/p53-apoptosis signaling pathway.
24
AKT/NF‐κB inhibitor xanthohumol targets cell growth and angiogenesis in hematologic malignancies
Raffaella Dell’Eva, Claudia Ambrosini, Nicola Vannini et al. · Cancer · 2007 · 76 citations · Full text
Medicine, Oncology, Pharmacology +17